Source:http://linkedlifedata.com/resource/pubmed/id/20882442
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-10-6
|
pubmed:abstractText |
PAX5 is an essential transcription factor for the commitment of lymphoid progenitors to the B-lymphocyte lineage. PAX5 suppression results in retrodifferentiation of B lymphocytes to an uncommitted progenitor cell stage, whereas PAX5 suppression in mature B lymphocytes leads to further development into plasma cells. Here, we have analyzed the fate of plasma cell lines following PAX5 reexpression. Human B cell lines were infected with Ad5/F35 adenoviruses encoding either EYFP or PAX5. Expression analysis of specific plasma cell transcription factors (IRF4, Blimp-1 and XBP-1) suggests that PAX5 reexpression does not induce retrodifferentiation of plasma cells into B lymphocytes. Interestingly, the viability of RPMI-8226 and U266 multiple myeloma cell lines markedly declined at 4-7 days post-transduction, whereas other plasma cell lines maintained their viability. Apoptosis analysis through Annexin V measurement also revealed a higher level of apoptosis in PAX5-expressing myeloma cell lines. Finally, Western blot analysis of pro- and anti-apoptotic proteins revealed that the anti-apoptotic protein MCL-1 was down-modulated in PAX5-transduced multiple myeloma cell lines. In conclusion, our results show that the expression of PAX5 in plasma cell lines induces apoptosis exclusively in multiple myelomas. This might represent a potential therapeutic avenue in the treatment of multiple myeloma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1865-3774
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
451-62
|
pubmed:meshHeading |
pubmed-meshheading:20882442-Apoptosis,
pubmed-meshheading:20882442-B-Cell-Specific Activator Protein,
pubmed-meshheading:20882442-Cell Line, Tumor,
pubmed-meshheading:20882442-Cell Survival,
pubmed-meshheading:20882442-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20882442-Humans,
pubmed-meshheading:20882442-Multiple Myeloma,
pubmed-meshheading:20882442-Transcription Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Overexpression of PAX5 induces apoptosis in multiple myeloma cells.
|
pubmed:affiliation |
Héma-Québec, Quebec, G1V 5C3, QC, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|